EUVIMEDEUVIMED entdecken
Crossref

Clinical and Pathological Significance of GLUT ‐1 Expression in Angiosarcoma and Other Vascular Tumors

Aya Hashimoto iD, Yuna Noda, Yutaka Inaba, Kayo Kunimoto, Yuki Yamamoto, Yumi Nakatani, Mamiko Masuzawa iD, Mikio Masuzawa, Yasuyuki Amoh, Masatoshi Jinnin

The Journal of Dermatology · 2026

DOI: 10.1111/1346-8138.70147 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, 2026. Verfasst von Aya Hashimoto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Wakayama Medical University, Wakayama, Wakayama, Japan. Hauptthemen laut MEDLINE: Glucose Transporter Type 1, Hemangiosarcoma, Biomarkers, Tumor, Hemangioma. Die Arbeit nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vascular anomalies are classified according to the ISSVA classification into vascular tumors with endothelial proliferation and vascular malformations without proliferation. Infantile hemangioma is a vascular tumor that is diagnosed by GLUT‐1 immunoreactivity. GLUT‐1 positivity is reportedly sometimes observed in angiosarcoma, but the clinical significance remains unclear. Here, immunohistochemistry was performed on tissue samples from patients with angiosarcoma ( n = 10), pyogenic granuloma ( n = 9), and senile hemangioma ( n = 10), with infantile hemangioma serving as a positive control. GLUT‐1 expression was detected in the cytoplasm and/or cell membrane of tumor cells in all cases of angiosarcoma (100%), as well as in the cytoplasm of some cases of pyogenic granuloma (44.4%) and senile hemangioma (40%). Double immunofluorescent staining for GLUT‐1 and CD34 revealed co‐expression in tumor endothelial cells of angiosarcoma. Clinically, cases of angiosarcoma with strong membranous GLUT‐1 expression tended to be associated with tumor progression, while those with weak or mild cytoplasmic expression showed a better response to treatment. These findings suggest that GLUT‐1 may serve as a useful marker of tumor progression for angiosarcoma, and as a potential therapeutic target in vascular tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucose Transporter Type 1HemangiosarcomaBiomarkers, TumorHemangiomaGranuloma, PyogenicSkin NeoplasmsHumansFemaleMaleImmunohistochemistryInfantChild, PreschoolDisease ProgressionChildCytoplasmAntigens, CD34Adolescent

Stichwörter der Autor:innen

GLUT‐1angiosarcomaimmunohistochemistry

Substanzen

Glucose Transporter Type 1SLC2A1 protein, humanBiomarkers, TumorAntigens, CD34

Autor:innen und Institutionen

  • Department of Dermatology, Wakayama Medical University, Wakayama, Wakayama, Japan.
  • Department of Dermatology, Kitasato University School of Medicine, Sagamihara, Kanagawa, Sagamihara, Kanagawa, Japan.

ORCID-Profile: Aya Hashimoto, Mamiko Masuzawa

Zitieren

APA

Hashimoto, A., Noda, Y., Inaba, Y., Kunimoto, K., Yamamoto, Y., Nakatani, Y., Masuzawa, M., Masuzawa, M., Amoh, Y., & Jinnin, M. (2026). Clinical and Pathological Significance of GLUT ‐1 Expression in Angiosarcoma and Other Vascular Tumors. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70147

Vancouver

Hashimoto A, Noda Y, Inaba Y, Kunimoto K, Yamamoto Y, Nakatani Y, et al. Clinical and Pathological Significance of GLUT ‐1 Expression in Angiosarcoma and Other Vascular Tumors. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70147

BibTeX
@article{Hashimoto2026,
  author = {Hashimoto, Aya and Noda, Yuna and Inaba, Yutaka and Kunimoto, Kayo and Yamamoto, Yuki and Nakatani, Yumi and Masuzawa, Mamiko and Masuzawa, Mikio and Amoh, Yasuyuki and Jinnin, Masatoshi},
  title = {Clinical and Pathological Significance of GLUT ‐1 Expression in Angiosarcoma and Other Vascular Tumors},
  journal = {The Journal of Dermatology},
  year = {2026},
  doi = {10.1111/1346-8138.70147}
}
Kostenlos starten →